Literature DB >> 18838523

Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.

Florent Meyer1, Raymonde Girardot, Yves Piémont, Gilles Prévost, Didier A Colin.   

Abstract

In this study, the binding of F components of the staphylococcal bicomponent leukotoxins Panton-Valentine leucocidin (LukF-PV) and gamma-hemolysin (HlgB) on polymorphonuclear neutrophils (PMNs), monocytes, and lymphocytes was determined using labeled mutants and flow cytometry. Leukotoxin activity was evaluated by measuring Ca(2+) entry or pore formation using spectrofluorometry or flow cytometry. Although HlgB had no affinity for cells in the absence of an S component, LukF-PV had high affinity for PMNs (dissociation constant [K(d)], 6.2 +/- 1.9 nM; n = 8), monocytes (K(d), 2.8 +/- 0.8 nM; n = 7), and lymphocytes (K(d), 1.2 +/- 0.2 nM; n = 7). Specific binding of HlgB was observed only after addition of LukS-PV on PMNs (K(d), 1.1 +/- 0.2 nM; n = 4) and monocytes (K(d), 0.84 +/- 0.31 nM; n = 4) or after addition of HlgC on PMNs, monocytes, and lymphocytes. Addition of LukS-PV or HlgC induced a second specific binding of LukF-PV on PMNs. HlgB and LukD competed only with LukF-PV molecules bound after addition of LukS-PV. LukF-PV and LukD competed with HlgB in the presence of LukS-PV on PMNs and monocytes. Use of antibodies and comparisons between binding and activity time courses showed that the LukF-PV molecules that bound to target cells before addition of LukS-PV were the only LukF-PV molecules responsible for Ca(2+) entry and pore formation. In contrast, the active HlgB molecules were the HlgB molecules bound after addition of LukS-PV. In conclusion, LukF-PV must be linked to LukS-PV and to a binding site of the membrane to have toxin activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838523      PMCID: PMC2612235          DOI: 10.1128/IAI.00402-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Tyrosine72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the staphylococcal gamma-hemolysin to human erythrocytes.

Authors:  K Yokota; Y Kamio
Journal:  Biosci Biotechnol Biochem       Date:  2000-12       Impact factor: 2.043

2.  Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore.

Authors:  George Miles; Liviu Movileanu; Hagan Bayley
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

3.  Retrieving biological activity from LukF-PV mutants combined with different S components implies compatibility between the stem domains of these staphylococcal bicomponent leucotoxins.

Authors:  S Werner; D A Colin; M Coraiola; G Menestrina; H Monteil; G Prévost
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Controlling pore assembly of staphylococcal gamma-haemolysin by low temperature and by disulphide bond formation in double-cysteine LukF mutants.

Authors:  Vananh T Nguyen; Hideo Higuchi; Yoshiyuki Kamio
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501

5.  Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains.

Authors:  V Finck-Barbançon; G Prévost; Y Piémont
Journal:  Res Microbiol       Date:  1991-01       Impact factor: 3.992

Review 6.  Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin.

Authors:  Susan Boyle-Vavra; Robert S Daum
Journal:  Lab Invest       Date:  2006-12-04       Impact factor: 5.662

7.  Flow cytometric determination of Panton-Valentine leucocidin S component binding.

Authors:  V Gauduchon; S Werner; G Prévost; H Monteil; D A Colin
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia.

Authors:  Maria Labandeira-Rey; Florence Couzon; Sandrine Boisset; Eric L Brown; Michele Bes; Yvonne Benito; Elena M Barbu; Vanessa Vazquez; Magnus Höök; Jerome Etienne; François Vandenesch; M Gabriela Bowden
Journal:  Science       Date:  2007-01-18       Impact factor: 47.728

9.  Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins.

Authors:  Didier A Colin; Henri Monteil
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study.

Authors:  B Cribier; G Prévost; P Couppie; V Finck-Barbançon; E Grosshans; Y Piémont
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

View more
  27 in total

1.  Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins.

Authors:  Benoît-Joseph Laventie; Hendrik Jan Rademaker; Maher Saleh; Ernie de Boer; Rick Janssens; Tristan Bourcier; Audrey Subilia; Luc Marcellin; Rien van Haperen; Joyce H G Lebbink; Tao Chen; Gilles Prévost; Frank Grosveld; Dubravka Drabek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components.

Authors:  Keitaro Yamashita; Yuka Kawai; Yoshikazu Tanaka; Nagisa Hirano; Jun Kaneko; Noriko Tomita; Makoto Ohta; Yoshiyuki Kamio; Min Yao; Isao Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

3.  Crystallization and preliminary crystallographic studies of both components of the staphylococcal LukE-LukD leukotoxin.

Authors:  Romain Galy; Fabien Bergeret; Daniel Keller; Lionel Mourey; Gilles Prévost; Laurent Maveyraud
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

4.  Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Authors:  Angelino T Tromp; Michiel Van Gent; Pauline Abrial; Amandine Martin; Joris P Jansen; Carla J C De Haas; Kok P M Van Kessel; Bart W Bardoel; Elisabeth Kruse; Emilie Bourdonnay; Michael Boettcher; Michael T McManus; Christopher J Day; Michael P Jennings; Gérard Lina; François Vandenesch; Jos A G Van Strijp; Robert Jan Lebbink; Pieter-Jan A Haas; Thomas Henry; András N Spaan
Journal:  Nat Microbiol       Date:  2018-05-07       Impact factor: 17.745

Review 5.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 6.  Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.

Authors:  András N Spaan; Jos A G van Strijp; Victor J Torres
Journal:  Nat Rev Microbiol       Date:  2017-04-19       Impact factor: 60.633

Review 7.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

8.  Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome.

Authors:  Dirk Holzinger; Laura Gieldon; Vijayashree Mysore; Nadine Nippe; Debra J Taxman; Joseph A Duncan; Peter M Broglie; Kristina Marketon; Judith Austermann; Thomas Vogl; Dirk Foell; Silke Niemann; Georg Peters; Johannes Roth; Bettina Löffler
Journal:  J Leukoc Biol       Date:  2012-08-14       Impact factor: 4.962

Review 9.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

Review 10.  The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond.

Authors:  Pauline Yoong; Victor J Torres
Journal:  Curr Opin Microbiol       Date:  2013-02       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.